SCHEMBL29845765

SCHEMBL29845765

CC[Si](CC)(c1cccc(N)c1)c1cccc(N)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.46
CASP1 P29466 1/20 0.46
RECQL P46063 1/20 0.46
TP53 P04637 1/20 0.44
ESR1 P03372 2/20 0.42
AR P10275 1/20 0.42
ESR2 Q92731 1/20 0.42
ALDH1A1 P00352 3/20 0.39
TSHR P16473 2/20 0.39
MAPK1 P28482 1/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CA14 Q9ULX7 1/20 0.38
MAOA P21397 2/20 0.38
MAOB P27338 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3036362 1.00 CYP3A4 (0.46) CYP3A4CASP1RECQLTP53ESR1
SCHEMBL4453580 0.76 CYP3A4 (0.47) CYP3A4CASP1RECQLTP53ALDH1A1
SCHEMBL6422988 0.75 CYP3A4 (0.52) CYP3A4CASP1RECQLTP53ESR1
SCHEMBL30825584 0.75 CYP3A4 (0.52) CYP3A4CASP1RECQLTP53ALDH1A1
SCHEMBL29437105 0.75 CYP3A4 (0.52) CYP3A4CASP1RECQLTP53ESR1
SCHEMBL1172290 0.75 CYP3A4 (0.52) CYP3A4CASP1RECQLTP53ALDH1A1
SCHEMBL3886730 0.74 CYP3A4 (0.58) CYP3A4CASP1RECQLALDH1A1TSHR
SCHEMBL434177 0.74 CYP3A4 (0.48) CYP3A4CASP1RECQLTP53ALDH1A1
SCHEMBL30022263 0.74 CYP3A4 (0.48) CYP3A4CASP1RECQLTP53ALDH1A1
SCHEMBL7132361 0.74 TSHR (0.42) CYP3A4CASP1RECQLTP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260071043-A1 ARTICLES COMPRISING A COMBINATION OF POLYMER AEROGEL AND MELAMINE-FORMALDEHYDE FOAM AND RELATED SYSTEMS AND METHODS AEROGEL TECHNOLOGIES, LLC (US) 2026-03-12 US disclosed
US-20250270371-A1 HYDROPHOBIC POLYIMIDE AEROGELS AEROGEL TECHNOLOGIES, LLC (US) 2025-08-28 US disclosed
EP-4384389-A2 THERMAL PROTECTION LAMINATES Blueshift Materials, Inc. (US) 2024-06-19 EP disclosed
WO-2023086688-A2 THERMAL PROTECTION LAMINATES Blueshift Materials, Inc. (US) 2023-05-19 WO disclosed
EP-4041435-A1 HYDROPHOBIC POLYIMIDE AEROGELS Aerogel Technologies, LLC (US) 2022-08-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260071043-A1 ARTICLES COMPRISING A COMBINATION OF POLYMER AEROGEL AND MELAMINE-FORMALDEHYDE FOAM AND RELATED SYSTEMS AND METHODS FLNA, FLNB, FUS CYP3A4 1401/4885CASP1 2677/4885RECQL 991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.